BATON ROUGE, La., Nov. 2, 2021 /PRNewswire/ -- Mary Bird Perkins Cancer Center, a leading Gulf South cancer care provider for more than 50 years, and OneOncology, the national platform for independent oncology practices, today announced the organizations have finalized agreements to become partners, effective Jan. 1, 2022. This partnership will expand access to resources for cancer patients at every Mary Bird Perkins Cancer Center location with an approach unlike any other in the region.
Mary Bird Perkins is an independent, community-owned nonprofit organization serving patients throughout southeast Louisiana and southwest Mississippi. The Cancer Center, with its unparalleled track record of focusing exclusively on cancer, is a national leader in clinical research, prevention and early detection and patient care. OneOncology focuses solely on enhancing community-based cancer care.
"There are so many benefits to partnering with a like-minded organization such as OneOncology. They've done the research, and just like us, they understand that patients battling cancer want to be cared for by a team that focuses entirely on high-quality cancer care," said Tom Adamek, board chairman, Mary Bird Perkins Cancer Center. "Throughout the process of defining our relationship with OneOncology, they have been clear, straight-forward and, like Mary Bird Perkins, always placing the patient first. I can't wait to see what the future holds for both organizations. It's going to be amazing for patients in Louisiana and the Gulf South."
Ad Statistics
Times Displayed: 21862
Times Visited: 433 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
There are numerous benefits for patients and Mary Bird Perkins that will soon be noticeable:
Through OneR, OneOncology's research network, new clinical trials will be available to patients, offering new opportunities to participate in a study that may enhance their treatment and how cancer care advances for future generations.
In some cases, infusion drug costs and medical supplies for patients and insurance companies may drop below the national average as a result of OneOncology's national buying power.
Efforts will begin to further expand services and recruit additional oncologists to the Mary Bird Perkins network.
The relationship with OneOncology will ensure the Cancer Center can continuously reinvest in advanced treatments, technologies and support services.
A new Electronic Medical Records platform and technology support will allow Mary Bird Perkins to focus resources on expanding patient services and pursuing clinical advancements.
